YY/T 0618-2017 in English
VALIDTest methods for bacterial endotoxins of medical devices―Routine monitoring and alternatives to batch testing
- Issued on:2017-02-28
- Implemented on:2018-01-01
- File Format:PDF
- Delivery:Via email within 5 business days
$476.00
本标准规定了测定医疗器械、组件或原材料的细菌内毒素试验方法的基本准则。
本标准适用于医疗器械细菌内毒素常规监控与跳批检验。
Introduction
Standard Overview
YY/T 0618-2017 replaces the 2007 version of the standard. The main updates include: standard name adjustment, new terminology (endotoxin working standard, geometric mean endpoint, etc.), and revision of appendix content. This standard is applicable to endotoxin detection of medical devices, components and raw materials, and is not applicable to pyrogen evaluation of non-bacterial endotoxins.
Analysis of core terms
| Terms | Definition | Key points |
|---|---|---|
| Bacterial endotoxin test (BET) | A method of detecting activity by reacting Limulus reagent with endotoxin | Including three techniques: gel method, colorimetric method and turbidity method |
| Maximum effective dilution (MVD) | The maximum allowable dilution ratio to overcome interference | Calculation formula: MVD=test endotoxin limit/λ |
| Skip batch inspection | A plan to reduce inspection frequency based on process control | Requires FMEA and other risk assessments |
Comparison of test methods
Three main technical features:
- Gel technology: easy to operate, low equipment requirements, subjective result interpretation
- Colorimetric/turbidity endpoint method: requires a microplate reader, with a linear range of 1 logarithmic level
- Kinetic method: high degree of automation, with a linear range of up to 4 logarithmic levels
The standard recommends selecting an appropriate method based on laboratory conditions and sample characteristics, and revalidation is required when changes are made.
Key points for implementation
- Sample preparation: The volume of the extract must ensure the detection limit, and multi-component products must consider the overall extraction strategy
- Interference treatment: Methods such as pH adjustment, ion concentration adjustment, and ultrafiltration concentration must be used after verification
- Skip batch inspection: The prerequisites of stable production process, qualified historical data, and critical control point monitoring must be met
Background of standard evolution
Bacterial endotoxin testing began in the 1970s and was officially adopted by USP in 1993. The limit values for medical devices are set based on safety considerations:
- Conventional devices: 20 EU/unit
- Cerebral spinal fluid contact devices: 2.15 EU/unit
- Limits for extracts: 0.5 EU/mL (conventional)/0.06 EU/mL (cerebrospinal fluid)
In 2004, AAMI research confirmed that the current limits already include safety factors, and no additional recovery rate requirements are required.

Loading PDF document...
Error loading PDF. Please make sure the file is valid and try again.
We also recommend
-

YY/T 1987-2025 in English
Medical devices using brain-computer interface technology
2025-09-15 -

YY/T 1939-2024 in English
Test method for bacterial endotoxins in medical devices - Recombinant factor C method
2024-07-08 -

YY/T 1960-2025 in English
Information provided by medical device manufacturers
2025-06-18 -

YY/T 0316-2016 in English
Medical devices-Application of risk management to medical devices
2016-01-26